Skip to main navigation menu Skip to main content Skip to site footer

HOW TO REDUCE THE RISK OF ISCHEMIC STROKE?

Abstract

Ischemic stroke, characterized by the obstruction of blood flow to the brain due to thrombotic or embolic events, remains a leading cause of morbidity and mortality worldwide. This article explores evidence-based strategies to reduce the risk of ischemic stroke by addressing modifiable risk factors and implementing preventative measures. Key risk factors include hypertension, diabetes mellitus, hyperlipidemia, atrial fibrillation, smoking, and sedentary lifestyle. Effective risk reduction strategies encompass blood pressure management, glycemic control, lipid-lowering therapies, anticoagulation in atrial fibrillation, smoking cessation, and regular physical activity. Recent studies highlight the role of dietary modifications, particularly the adoption of the Mediterranean diet, and the importance of maintaining optimal body mass index (BMI) in stroke prevention (Feigin et al., 2021; Kernan et al., 2014). Additionally, pharmacological interventions such as antiplatelet agents (e.g., aspirin) and statins play a crucial role in secondary prevention (Hackam & Spence, 2020). Public health initiatives focusing on awareness and early detection of risk factors are vital in reducing stroke incidence. This article emphasizes a comprehensive approach combining lifestyle modification, medical management, and community education to mitigate ischemic stroke risk effectively.

Keywords

Ischemic Stroke, Risk Reduction, Prevention Strategies, Hypertension, Diabetes Mellitus, Hyperlipidemia, Atrial Fibrillation, Smoking Cessation, Physical Activity, Antiplatelet Therapy, Statins, Mediterranean Diet, Blood Pressure Management, Glycemic Control

DOWNLOAD PDF

References

  1. Amarenco, P., Bogousslavsky, J., Callahan, A., Goldstein, L. B., Hennerici, M. G., Rudolph, A. E., ... & Welch, K. M. (2006). High-dose atorvastatin after stroke or transient ischemic attack. New England Journal of Medicine, 355(6), 549–559. https://doi.org/10.1056/NEJMoa061894
  2. Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., ... & Wallentin, L. (2009). Dabigatran versus warfarin in patients with atrial fibrillation. New England Journal of Medicine, 361(12), 1139–1151. https://doi.org/10.1056/NEJMoa0905561
  3. Emerging Risk Factors Collaboration. (2010). Diabetes mellitus, fasting glucose, and risk of cause-specific death. New England Journal of Medicine, 364(9), 829–841. https://doi.org/10.1056/NEJMoa1008862
  4. Estruch, R., Ros, E., Salas-Salvadó, J., Covas, M. I., Corella, D., Arós, F., ... & Martínez-González, M. A. (2013). Primary prevention of cardiovascular disease with a Mediterranean diet. New England Journal of Medicine, 368(14), 1279–1290. https://doi.org/10.1056/NEJMoa1200303
  5. Feigin, V. L., Norrving, B., & Mensah, G. A. (2021). Global burden of stroke. Circulation Research, 128(9), 1523–1540. https://doi.org/10.1161/CIRCRESAHA.121.318160
  6. Hart, R. G., Pearce, L. A., & Aguilar, M. I. (2012). Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Annals of Internal Medicine, 146(12), 857–867. https://doi.org/10.7326/0003-4819-146-12-200706190-00007
  7. Lawes, C. M., Rodgers, A., & Bennett, D. A. (2004). Blood pressure and stroke: An overview of published reviews. Stroke, 35(4), 1024–1033. https://doi.org/10.1161/01.STR.0000113849.55138.96
  8. Lee, C. D., Folsom, A. R., & Blair, S. N. (2003). Physical activity and stroke risk: A meta-analysis. Stroke, 34(10), 2475–2481. https://doi.org/10.1161/01.STR.0000091089.59528.03
  9. O'Donnell, M. J., Xavier, D., Liu, L., Zhang, H., Chin, S. L., Rao-Melacini, P., ... & Yusuf, S. (2010). Risk factors for ischemic and intracerebral hemorrhagic stroke in 22 countries (the INTERSTROKE study): A case-control study. The Lancet, 376(9735), 112–123. https://doi.org/10.1016/S0140-6736(10)60834-3
  10. SPRINT Research Group. (2015). A randomized trial of intensive versus standard blood-pressure control. New England Journal of Medicine, 373(22), 2103–2116. https://doi.org/10.1056/NEJMoa1511939
  11. Zoungas, S., Chalmers, J., Neal, B., Billot, L., Li, Q., Hirakawa, Y., ... & Woodward, M. (2014). Follow-up of blood-pressure lowering and glucose control in type 2 diabetes. New England Journal of Medicine, 371(15), 1392–1406. https://doi.org/10.1056/NEJMoa1407963
  12. Umarovna, Q. Y., & Xalilovna, U. S. (2024). PRAGMATICS AND DISCOURSE ANALYSIS ACROSS CULTURES: STUDYING HOW CULTURAL CONTEXTS INFLUENCE PRAGMATIC USAGE AND DISCOURSE PATTERNS IN COMPARATIVE LINGUISTICS. YANGI O ‘ZBEKISTON, YANGI TADQIQOTLAR JURNALI, 1(3), 357-361.
  13. Qurbonova, Y., & Yahyoyev, M. (2024). PRAGMATICS AND ACTIVITY EVALUATION IN TEACHING. Talqin va tadqiqotlar.
  14. Shahloxon, B., & Yulduz, Q. (2024). FLIPPED CLASSROOM MODEL. ANALYZE THE EFFECTIVENESS OF THE FLIPPED CLASSROOM APPROACH COMPARED TO TRADITIONAL TEACHING METHODS IN VARIOUS SUBJECTS OR GRADE LEVELS. Yangi O ‘zbekiston ustozlari, 2(28), 128-134.
  15. Sevinch, O., & Yulduz, Q. (2024). LITERATURE AS A REFLECTION OF SOCIAL CHANGE: STUDY-SPECIFIC LITERARY MOVEMENTS (EG, MODERNISM, FEMINISM) AND THEIR RESPONSES TO SOCIETAL SHIFTS DURING THEIR RESPECTIVE PERIODS. Yangi O ‘zbekiston ustozlari, 2(27), 79-83.
  16. Umarovna, Y. Q., & Sabriddinovich, M. Y. (2024). THE IMPACT OF EMPLOYING TELEGRAM IN LEARNING.". Science Shine" International scientific journal, 12(1).
  17. Umarovna, Q. Y. (2024). LITERATURE REVIEW: IMPORTANCE OF NOTE-TAKING. Ta'limda raqamli texnologiyalarni tadbiq etishning zamonaviy tendensiyalari va rivojlanish omillari, 30(1), 28-32.
  18. Umarovna, Q. Y. (2024). Pragmatics and Awareness–Raising Tasks in Language Learning. Excellencia: International Multi-disciplinary Journal of Education (2994-9521), 2(4), 154-157.

Downloads

Download data is not yet available.